The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Baĭdina T.V.

GBOU VPO "Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera", Perm'

Danilova M.A.

GBOU VPO "Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera" Minzdrava RF, Perm'

Mishlanov V.Yu.

Vagner Perm State Medical University, Perm, Russia

Lipoprotein (a) in patients with carotid atherosclerosis

Authors:

Baĭdina T.V., Danilova M.A., Mishlanov V.Yu.

More about the authors

Read: 950 times


To cite this article:

Baĭdina TV, Danilova MA, Mishlanov VYu. Lipoprotein (a) in patients with carotid atherosclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8):82‑84. (In Russ.)
https://doi.org/10.17116/jnevro201811808182

Recommended articles:
Stroke: current state of the problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):7-18
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
Connectome in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):46-50
Differentiated approach to cognitive reha­bilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120

References:

  1. Jacobson TA. Lipoprotein(a), cardiovascular disease, and contemporary management. Mayo Clin Proc. 2013;88(11):1294-2311. https://doi.org/10.1016/j.mayocp.2013.09.003
  2. Bucci M, Tana C, Giamberardino MA, Cipollone F. Lp(a) and cardiovascular risk: Investigating the hidden side of the moon. Nutr Metab Cardiovasc Dis. 2016;26(11):980-986. https://doi.org/10.1016/j.numecd.2016.07.004
  3. Kotani K, Serban MC, Penson P, Lippi G, Banach M. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases — Some answers and still many questions. Crit Rev Clin Lab Sci. 2016;53(6):370-378. https://doi.org/10.1080/10408363.2016.1188055
  4. Lakshminarayan D, Elajami TK, Devabhaktuni S, Welty FK. Ischemic stroke in a young adult with extremely elevated lipoprotein(a): A case report and review of literature. J Clin Lipidol. 2016;10(5):1266-1271. https://doi.org/10.1016/j.jacl.2016.06.012
  5. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115. https://doi.org/10.1016/0140-6736(92)93147-F
  6. Tuev AV, Mishlanov VYu. Experimental prerequisites of new atherosclerosis theory. Bolezni serdechno-sosudistoj sistemy: teoriya i praktika. Materialy I s’ezda kardiologov Privolzhskogo i Ural’skogo Federal’nyh okrugov Rossiiskoi Federatsii. 2003;258-265. (In Russ.) Accessed February 27, 2017. http://elibrary.ru/item.asp?id=23818532
  7. Baidina TV, Mishlanov VYu, Syutkina OV. Lipidvysvobozhdajushhaja sposobnost’ lejkocitov kak nespecificheskij marker immunnogo vopalenija pri aterotromboticheskom insul’te. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2006;8:54. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.